cdmo.directory
← Compare landing

Cell and Gene Therapy Catapult vs Synthego

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCell and Gene Therapy CatapultSynthego
SummaryUK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
Services
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Viral Vector
  • Single-Use / Disposable
  • Drug Substance (DS)
  • Expression: Cell-Free
Locations
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cell and Gene Therapy Catapult alternatives · Synthego alternatives

Markdown mirror: /compare/ct/synthego.md